Skip to the board
Health

Mental Health

Washington Bird Flu Death Highlights Rare H5N5 Infection After Cattle Exposure

Theresa Gaffney 322 views

A Washington resident died after an H5N5 infection linked to cattle exposure. The case is rare, while several other health reports raise questions about safety and access.

Washington Bird Flu Death Highlights Rare H5N5 Infection After Cattle Exposure
NIAID

A Washington resident’s death after contracting bird flu is a rare and serious outcome, but it doesn’t change the broader picture described in recent years: many reported infections have been milder than researchers expected. The case involved H5N5, a less common version of the virus, and followed exposure to cattle. It was the first bird flu death reported in the United States this year and the third since the illness became a major concern in 2024.

What the Washington case adds

The first two U.S. deaths since 2024 involved H5N1. The Washington case was attributed to H5N5, underscoring that bird flu infections can involve different virus types. The source report doesn’t provide further clinical details about the person or explain how the infection occurred beyond noting cattle exposure. It also doesn’t establish how often this particular version causes severe illness.

That leaves a careful distinction for readers: a fatal case signals that severe disease can happen, but it can’t by itself show how likely severe illness is for someone exposed, or how the risk compares across virus types. Earlier infections over the past few years were often milder than expected, a pattern that has brought relief while leaving scientists with questions.

Exposure to infected animals is a relevant part of the story. Raw milk is also a known concern when bird flu is circulating in cattle. The cited reporting has advised against drinking it. Anyone with questions about a possible exposure or illness can discuss their circumstances with a health care professional.

Read more about the Washington case.

Generic HIV prevention medicine moves closer to wider access

Lenacapavir, an injectable medicine for HIV prevention, is given once every six months. The source describes it as offering near-complete protection against HIV. More than a year after the brand-name version was approved, Dr. Reddy’s Laboratories received tentative approval to make a generic version.

The step follows licensing agreements Gilead Sciences reached two years earlier with six generic drugmakers, including Dr. Reddy’s. Those agreements cover production and distribution in 120 countries, most of them low or middle income. The report says the generic could improve access, but doesn’t specify its eventual price or explain when it will become available in each country. Those details will shape how much the change matters in practice.

For people considering HIV prevention, the news is about a possible future access option, not a reason to change care now. A clinician or pharmacist can help explain which prevention approaches are available and suitable for an individual.

Questions grow around mitochondrial replacement in fertility care

Mitochondrial replacement technology, sometimes called “three-parent IVF,” was developed to reduce the chance of passing certain serious mitochondrial diseases from a mother to a child. Some fertility clinics have also promoted the procedure to older women seeking biological children, though the source describes evidence for that use as limited.

That expansion has prompted debate about safety, effectiveness and ethics. Bert Smeets, a clinical genomics professor who serves on the committee reviewing applications at the only U.K. clinic licensed to perform the procedure, said the public may see it as safer and lower risk than the evidence supports. Researchers’ concerns extend beyond fertility use to questions about the approach itself.

The distinction between the procedure’s original purpose and its promotion as an infertility treatment matters. Evidence that a method may reduce the risk of a specific inherited disease doesn’t automatically establish that it helps people have children or that its risks are well understood. People weighing fertility treatment can ask clinics what evidence supports the proposed use, what uncertainties remain and what alternatives are available.

Motorized bike injuries among children

An analysis of emergency room data from six medical institutions found that 10% of minors who went to the ER after an electric bike accident had brain injuries. That was twice the rate reported for injuries involving non-motorized bikes. The analysis covered data from 2023 through early 2026 and was published in JAMA.

Researchers also found that injuries involving electric bikes and scooters increased faster over the study period than injuries involving traditional bikes and scooters. Children hurt on motorized vehicles tended to be older, yet children under 12 accounted for 24% of electric bike injuries and 44% of electric scooter trauma in the data.

These figures describe children who came to emergency departments; they don’t measure every crash or establish why injury rates changed. Still, they highlight that motorized rides can bring different injury patterns, including head injuries, and that younger children were part of the reported cases.

A physician reflects on staying present with patients

Ophthalmologist Robert Kinast attended a meditation retreat in the Santa Cruz Mountains last fall, hoping to take a break from a demanding practice. During an overnight meditation, memories of severe eye injuries he had treated resurfaced, including injuries involving knives, fireworks, bungee cords, windshields and other objects.

Kinast writes that the experience changed how he thinks about the connection between reflection and patient care. His account focuses on staying grounded while caring for people with traumatic injuries. It’s a personal essay, rather than research testing whether meditation improves clinical outcomes, but it offers a clinician’s perspective on how self-awareness can shape conversations with patients.

Together, these reports point to practical questions that matter beyond the headlines: what an infection or injury study can and can’t tell us, how access to prevention medicines may change, and what evidence supports emerging treatments. For personal decisions about exposure, prevention or fertility care, a health professional can help put the available information into context.

Source: Theresa Gaffney · www.statnews.com

From the same roll